AGR2 and neoplasm: Collectively, these findings imply that multiple splice variants of AGR2 may be present in the same cancer cell lines or in the same cancer patients, and that ER-resident and secreted AGR2 may simultaneously be involved in tumor development and chemotherapeutic sensitivity.